Related Experiment Video

Updated: Jun 15, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.6K

Missed opportunities to increase efficiency of monoclonal antibody development using hybridoma technology and mice as

Esha Chakravarty1, Mehmet T Dorak1

  • 1School of Life Sciences, Pharmacy & Chemistry, Kingston University London, London, United Kingdom.

Frontiers in Immunology
|August 27, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BALB/cMHC restrictionTh2 immune responseantigen presentationhistocompatibilityhybridomamicemonoclonal antibody development

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.4K
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

10.9K

Related Experiment Videos

Last Updated: Jun 15, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.6K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.4K
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

10.9K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

14.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.2K

Articles linked to this work by shared authors, journal, and citation graph.

The Magnitude of Postconvulsive Leukocytosis Mirrors the Severity of Periconvulsive Respiratory Compromise: A Single Center Retrospective Study.

Frontiers in neurology·2019

Plasma Free Fatty Acids Metabolic Profile with LC-MS and Appetite-Related Hormones in South Asian and White European Men in Relation to Adiposity, Physical Activity and Cardiorespiratory Fitness: A Cross-Sectional Study.

Metabolites·2019

Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis.

Rheumatology (Oxford, England)·2018

Genetic Associations of PPARGC1A with Type 2 Diabetes: Differences among Populations with African Origins.

Journal of diabetes research·2015

Birth Characteristics and Childhood Leukemia Risk: Correlations With Genetic Markers.

Journal of pediatric hematology/oncology·2015

Correction: Astrocyte-derived HMGB1 compromises the integrity of the blood-brain barrier through the CaM/CaMKII/AQP4 pathway and the protective function of trifluoperazine.

Frontiers in immunology·2026

RNA therapeutics in rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis: a compartment-aware translational framework.

Frontiers in immunology·2026

Correction: Evaluating the in vivo effects of Aspirin on vaginal inflammation and barrier function.

Frontiers in immunology·2026

Inflammation identity crisis: pathogenic nature of platelet-derived transforming growth factor β in chronic inflammatory conditions.

Frontiers in immunology·2026

The emerging role of CRISPR-Cas systems in helicobacter pylori and the gut microbiota as regulators of gastrointestinal cancer risk.

Frontiers in immunology·2026

Innate immune cells in tumor immunity: dual roles, mechanistic insights, and therapeutic opportunities.

Frontiers in immunology·2026

Severe perioperative immune-related adverse events requiring intensive care in patients with gastric cancer: a case series.

Journal of medical case reports·2026

Ileorectal fistula after resection of perforated sigmoid tumor and Hartmann's procedure with uterine invasion: a case report.

Journal of medical case reports·2026

[Intravenous Thrombolysis for Acute Ischemic Stroke: Current Evidence and Perspectives].

No shinkei geka. Neurological surgery·2026

Maternal immunoglobulin G anti-A and anti-B antibody titres for predicting neonatal immune sensitisation in ABO-incompatible pregnancies: The Maternal Anti-A and Anti-B Antibody Titres in ABO-Incompatible Pregnancies study.

Vox sanguinis·2026

The Effectiveness of Emotion Regulation-Based Therapy on Emotion Regulation, Cognitive Flexibility, and Symptom Severity in Patients with Irritable Bowel Syndrome.

Clinics and research in hepatology and gastroenterology·2026

Mechanistic basis for the selective recognition of the Fcγ receptor IIa by monoclonal antibody IV.3.

Journal of structural biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us